News

The company will fund an in vitro bladder cancer study at the University of Virginia that will collect data by upregulating the Senesco’s Factor 5A gene in a

The FDA granted orphan drug status upon review of an application containing data from both preclinical and in vitro studies demonstrating the multiple effects of 2-methoxyestradiol named 2ME

HuMax-CD38 is a human IgG1,k antibody selected from a large panel of antibodies based on its ability to bind and to kill multiple myeloma tumor cells. The HuMax-CD38

An independent data monitoring committee completed a planned review of interim results and concluded that the data are unlikely to provide evidence of significant effect. No safety concerns

Bristol-Myers Squibb said that the divestiture of its Oncology Therapeutics Network (OTN) business reflects the company’s strategic focus on developing its pipeline and new product opportunities in unmet

Scripps, based in La Jolla, California, is one of largest private, non-profit research organizations in the US. The investigation will follow up on earlier studies at Antigen Express

The trial will evaluate the anti-tumor activity and tolerability of repeated doses of ADH-1 (Exherin) on an every three-week schedule in patients whose tumors express the molecular target,

This settlement arises out of a suit brought by Glaxo against Bentley in October 2003, alleging that Bentley had violated Glaxo’s patents in the production of paroxetine products

The project, the largest of its kind in China, was launched with the signing of a memorandum of understanding by Wang Longde, vice minister of health, and Judy